The Blood Glucose Level Increased in Parallel with the Heart Rate Following Cilostazol Administration in Three Diabetic Patients-Reference-Cited by-同舟云学术

The Blood Glucose Level Increased in Parallel with the Heart Rate Following Cilostazol Administration in Three Diabetic Patients

Published:2014 Issue:8 Volume:53 Page:859-863
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Aoki Yuji¹,Shimizu Mika²,Watanabe Nobuaki³

Affiliation:

1. Department of Internal Medicine, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, Japan

2. Department of Pharmacy, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, Japan

3. Department of Neurosurgery, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/53/8/53_53.1403/_pdf

Reference21 articles.

1. 1. Chi Y-W, Lavie CJ, Milani RV, White CJ. Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag 4: 1197-1203, 2008.

2. 2. Beebe HG, Dawson DL, Culter BS, et al. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med 159: 2041-2050, 1999.

3. 3. Elam MB, Heckman J, Crouse JR, et al. Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication. Arterioscler Thromb Vasc Biol 18: 1942-1947, 1998.

4. 4. Nakaya Y, Minami A, Sakamoto S, et al. Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a model of spontaneous NIDDM. Diabetes Obes Metab 1: 37-41, 1999.

5. 5. Park SY, Shin HK, Lee JH, et al. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription. J Pharmacol Exp Ther 329: 571-579, 2009.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Phosphodiesterase in the Biology and Pathology of Diabetes;International Journal of Molecular Sciences;2020-11-03

2. A Case Report on Cilostazol Induced Loss of Diabetic Control;Journal of Young Pharmacists;2018-10-12

3. Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update;Journal of Biomedical Science;2017-11-13

4. Cilostazol protects against microvascular brain injury in a rat model of type 2 diabetes;Neuroscience Research;2017-04

5. Effect of cilostazol in treating diabetes-associated microvascular complications;Endocrine;2017-03-14